drugset / Trial / NCT00020878
Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers
NaSingle-groupOpen-labelPrevention
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. Celecoxib may be effective in preventing lung cancer in tobacco smokers. PURPOSE: Phase II trial to study the effectiveness of celecoxib in preventing non-small cell lung cancer in tobacco smokers.
Timeline
- Start
- 2001-03
- Primary completion
- 2002-11
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | 400 mg | Oral |